Molecule restores cognition, memory in Alzheimer's disease model mice

UCLA Health researchers have identified a molecule, DDL-920, that restores cognitive functions and memory in Alzheimer's disease model mice by enhancing brain electrical rhythms. Unlike current FDA-approved Alzheimer’s drugs, DDL-920 revitalizes memory rather than just slowing decline. The study, led by Drs. Istvan Mody and Varghese John, represents a novel approach to Alzheimer's treatment, with potential applications for other conditions such as schizophrenia and depression.

• DDL-920 targets fast-firing neurons critical for memory.
• Restores cognition in Alzheimer's model mice.
• Works differently than plaque-removing drugs.
• May have applications for other brain disorders.
• Further research is needed for human trials.